πŸ‡ΊπŸ‡Έ FDA

Intelligence Β· Patent portfolio

United Therapeutics Europe Patents

Full USPTO pharma patent portfolio for United Therapeutics Europe β€” grant dates, expiration, and drug cross-links.

Patents
3,720
Expiring ≀24m
234

Quick answer

United Therapeutics Europe has 3,720 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 234 expire within 24 months β€” use filters for patent-cliff planning.

Page 32 of 78

  1. US 9505812

    Plasmodium falciparum antigens

    Expires Mon Nov 24 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 9506041

    Delivery of packaged RNA to mammalian cells

    Expires Mon Nov 24 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 9506032

    Engineered biological pacemakers

    Expires Mon Nov 24 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 9499821

    Preventing or treating viral infection using an inhibitor of the LSD1 protein, a MAO inhibitor or an inhibitor of LSD1 and a MAO inhibitor

    Expires Mon Nov 17 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 9498511

    Methods related to the treatment of neurodegenerative and inflammatory conditions

    Expires Mon Nov 17 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 9498526

    Human rotavirus vaccine strains and diagnostics

    Expires Mon Nov 17 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 9492564

    Dual specific immunotoxin for brain tumor therapy

    Expires Mon Nov 10 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 9492405

    Use of fenoterol and fenoterol analogues in the treatment of glioblastomas and astrocytomas

    Expires Mon Nov 10 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 9492439

    Amido compounds as RORΞ³t modulators and uses thereof

    Expires Mon Nov 10 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 9487563

    Virus-like particles and methods of use

    Expires Mon Nov 03 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 9487573

    Murine anti-NY-ESO-1 T cell receptors

    Expires Mon Nov 03 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 9486502

    Methods of administering interferon gamma to absorb fluid from the subretinal space

    Expires Mon Nov 03 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 9486518

    Membrane proximal region of HIV GP41 anchored to the lipid layer of a virus-like particle vaccine

    Expires Mon Nov 03 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 9481866

    Methods of producing T cell populations enriched for stable regulatory T-cells

    Expires Mon Oct 27 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 9475839

    Peptide-based inhibitor of interleukin-10 or interferon-gamma signaling

    Expires Mon Oct 20 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 9475862

    Neutralizing GP41 antibodies and their use

    Expires Mon Oct 20 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 9474795

    Polysaccharide-protein conjugate vaccines

    Expires Mon Oct 20 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 9474793

    Vaccines and methods for prevention and treatment of drug-resistant HIV-1 and hepatitis B virus

    Expires Mon Oct 20 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 9474797

    African swine fever virus georgia strain adapted to efficiently grow in the vero cell line

    Expires Mon Oct 20 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 9474796

    Crimean-Congo hemorrhagic fever virus vaccine

    Expires Mon Oct 20 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 9468208

    Disease control with tick phospholipase A2

    Expires Mon Oct 13 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 9464035

    Salicylic acid derivatives useful as glucocerebrosidase activators

    Expires Mon Oct 06 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 9464135

    Epithelial membrane protein-2 (EMP2) and proliferative vitroretinopathy (PVR)

    Expires Mon Oct 06 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 9463233

    Avirulent, immunogenic flavivirus chimeras

    Expires Mon Oct 06 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 9463234

    Attenuated african swine fever virus strain induces protection against challenge with homologous virulent parental virus georgia 2007 isolate

    Expires Mon Oct 06 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 9457132

    Controlled covalent attachment of bioactive bacteriophage for regulating biofilm development

    Expires Mon Sep 29 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 9458086

    Compositions and methods for adipocyte modulation

    Expires Mon Sep 29 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 9458215

    Compositions and methods for osteogenic gene therapy

    Expires Mon Sep 29 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 9458141

    Low molecular weight thyroid stimulating hormone receptor (TSHR) agonists

    Expires Mon Sep 29 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 9457052

    Allograft tolerance induction

    Expires Mon Sep 29 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 9458225

    Method for purifying lactoferrin

    Expires Mon Sep 29 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 9453019

    Linked purine pterin HPPK inhibitors useful as antibacterial agents

    Expires Mon Sep 22 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 9452973

    Modulators of the relaxin receptor 1

    Expires Mon Sep 22 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 9453239

    Recombinant MVA viruses expressing clade A/G, clade B, and clade C modified HIV env, gag and pol genes

    Expires Mon Sep 22 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 9446048

    Methods for treating leukemia and disorders mediated by CBFΞ² and RUNX1 proteins

    Expires Mon Sep 15 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 9447144

    MHC class II restricted T cell epitopes from the cancer antigen, NY ESO-1

    Expires Mon Sep 15 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 9439875

    Anxiolytic effect of pterostilbene

    Expires Mon Sep 08 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 9439978

    Multilayered magnetic micelle compositions and methods for their use

    Expires Mon Sep 08 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 9439979

    Epidermal growth factor receptor (EGFR) and methods of use in adenoviral-associated virus type 6 (AAV6) transduction

    Expires Mon Sep 08 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 9441041

    Use of antagonists of the interaction between HIV GP120 and Ξ±4Ξ²7 integrin

    Expires Mon Sep 08 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 9441019

    Influenza hemagglutinin protein-based vaccines

    Expires Mon Sep 08 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 9439935

    Recombinant rift valley fever (RVF) viruses and methods

    Expires Mon Sep 08 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 9441022

    Aegyptin and uses thereof

    Expires Mon Sep 08 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 9441048

    Antibody for 3β€²-isoLM1 and 3β€²,6β€²-iso-LD1 gangliosides

    Expires Mon Sep 08 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 9441050

    High-affinity monoclonal anti-prion antibodies

    Expires Mon Sep 08 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  46. US 9435000

    Primate T-lymphotropic viruses

    Expires Mon Sep 01 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  47. US 9427476

    Multivalent meningococcal conjugates and methods for preparing conjugates

    Expires Mon Aug 25 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  48. US 9428541

    Substrate reduction therapy

    Expires Mon Aug 25 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many patents does United Therapeutics Europe have?

3,720 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do United Therapeutics Europe patents expire?

234 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Where does this data come from?

USPTO PatentsView bulk data filtered to pharmaceutical CPC classes (A61K, A61P), cross-linked to NovaPharmaNews company and drug profiles. See our data sources page for methodology.

Data attribution: Data sources Β· Patent directory

Drug approvals, clinical trials, M&A, event intelligence, and company updates β€” weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.